Clinicopathological relevance of SMAD4 and RUNX3 in pancreatic cancer

被引：0
|
作者：
Hirose, Katsuya [1 ]
Yamamoto, Masakazu [2 ]
Furukawa, Toru [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Dept Histopathol, Sendai, Miyagi, Japan
[2] Tokyo Womens Med Univ, Dept Surg, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3366
引用
收藏
页码：1419 / 1419
页数：1
相关论文
共 50 条
  • [21] Prognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis
    Xing Shugang
    Yang Hongfa
    Liu Jianpeng
    Zheng Xu
    Feng Jingqi
    Li Xiangxiang
    Li Wei
    TRANSLATIONAL ONCOLOGY, 2016, 9 (01): : 1 - 7
  • [22] SMAD4 mutation acquisition in the metastatic transformation of pancreatic cancer.
    Grewal, Amardeep
    Ben-Josef, Edgar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [23] Organ-specific effects of Smad4 in metastatic pancreatic cancer
    Tsanov, Kaloyan M.
    Barriga, Francisco M.
    Ho, Yu-Jui
    Alonso-Curbelo, Direna
    Livshits, Geulah
    Koche, Richard
    Baslan, Timour
    Wuest, Alexandra N.
    Simon, Janelle
    Tian, Sha
    Luan, Wei
    Lowe, Scott W.
    CANCER RESEARCH, 2023, 83 (07)
  • [24] SMAD2, SMAD3 and SMAD4 Mutations in Colorectal Cancer
    Fleming, Nicholas I.
    Jorissen, Robert N.
    Mouradov, Dmitri
    Christie, Michael
    Sakthianandeswaren, Anuratha
    Palmieri, Michelle
    Day, Fiona
    Li, Shan
    Tsui, Cary
    Lipton, Lara
    Desai, Jayesh
    Jones, Ian T.
    McLaughlin, Stephen
    Ward, Robyn L.
    Hawkins, Nicholas J.
    Ruszkiewicz, Andrew R.
    Moore, James
    Zhu, Hong-Jian
    Mariadason, John M.
    Burgess, Antony W.
    Busam, Dana
    Zhao, Qi
    Strausberg, Robert L.
    Gibbs, Peter
    Sieber, Oliver M.
    CANCER RESEARCH, 2013, 73 (02) : 725 - 735
  • [25] Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma
    Yang, Yuewu
    Ye, Zhiqiang
    Zou, Zengcheng
    Xiao, Gemin
    Luo, Gangjian
    Yang, Hongzhi
    TUMOR BIOLOGY, 2014, 35 (10) : 10333 - 10340
  • [26] NO•/RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer
    Wang, Limin
    Tang, Wei
    Yang, Shouhui
    He, Peijun
    Wang, Jian
    Gaedcke, Jochen
    Stroebel, Philipp
    Azizian, Azadeh
    Ried, Thomas
    Gaida, Matthias M.
    Yfantis, Harris G.
    Lee, Dong H.
    Lal, Ashish
    Van den Eynde, Benoit J.
    Alexander, H. Richard
    Ghadimi, B. Michael
    Hanna, Nader
    Hussain, S. Perwez
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (11) : 3160 - 3169
  • [27] Runx3 in Immunity, Inflammation and Cancer
    Lotem, Joseph
    Levanon, Ditsa
    Negreanu, Varda
    Bauer, Omri
    Hantisteanu, Shay
    Dicken, Joseph
    Groner, Yoram
    RUNX PROTEINS IN DEVELOPMENT AND CANCER, 2017, 962 : 369 - 393
  • [28] Runx3、Smad4、Cdk2、p21在胃癌中的表达及其临床意义
    刘雷
    陈国昌
    宋振云
    郜恒骏
    陈卫昌
    胃肠病学, 2015, 20 (10) : 597 - 601
  • [29] MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer
    Hao, Jun
    Zhang, Shuyu
    Zhou, Yingqi
    Hu, Xiangui
    Shao, Chenghao
    FEBS LETTERS, 2011, 585 (01) : 207 - 213
  • [30] Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis
    Wang, Jin-Dao
    Jin, Ketao
    Chen, Xiao-Ying
    Lv, Jie-Qing
    Ji, Ke-Wei
    ONCOTARGET, 2017, 8 (10) : 16704 - 16711
12345